Sanofi has grown revenue 5.0% a year over three years and 3.9% a year over five, with earnings per share compounding at −1.5%. Revenue growth, 3-year annual rate: +5.0% (Drug Manufacturers - General median +6.3%). Revenue growth, 5-year rate: +3.9%, growth has picked up over the last three years. Earnings per share, 3-year rate: −1.5%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 11, FY2015 to FY2025, as filed.

SNYSanofi

HealthcareUSD

$45.44

$41.3152 weeks$49.59

Is it growing?

Is SNY growing?

Sanofi has grown revenue 5.0% a year over three years and 3.9% a year over five, with earnings per share compounding at −1.5%.

+5.0%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +6.3% · steady growth, ahead of inflation · compounded from fiscal years as filed

Revenue growth, 5-year rate: +3.9%
Revenue growth, 5-year rate · +5.0% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: −1.5%
Earnings per share, 3-year rate · revenue +5.0% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed